BC Faculty Seminar “Organophosphate insecticide toxicity from off-target effects“ by Assoc. Prof. Laran Jensen Department of Biochemistry, Faculty of Science, Mahidol University Join WebEx Meeting
Author: Webmaster
BC Special Seminar: September 7, 2022
BC Special Seminar “Addressing the Chemical Stability of g- and d-Lactams by Biocatalytic Methods” by Professor Mélanie Hall Institute of Chemistry, University of Graz, Austria
BC Special Seminar: August 31, 2022
BC Special Seminar “Bacteria farming to harvest functional nanocellulose materials” by Professor Anna Roig Serra Institute of Materials Science of Barcelone (ICMAB-CSIC), Spain Date: Wednesday,
Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach
Cholangiocarcinoma (CCA) has a complex immune microenvironment architecture, thus possessing challenges in its characterization and treatment. This study aimed to repurpose FDA-approved drugs for
In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma
Cholangiocarcinoma (CCA) is a heterogenous group of malignancies in the bile duct which proliferates aggressively. As a result, most patients are diagnosed in advanced
Druggable Allosteric Sites in β-Propeller Lectins
β-Propeller lectins are a group of carbohydrate binding proteins consisting of repetitive protomers arranged in a propeller configuration. These lectins emerged as new targets for
Targeting the Central Pocket of the Pseudomonas aeruginosa Lectin LecA
LecA is a carbohydrate-binding protein released by an opportunistic bacterium Pseudomonas aeruginosa, as part of a myriad of virulence factors and thus, a prime therapeutic
Targeting undruggable carbohydrate recognition sites through focused fragment library design
Carbohydrate binding proteins are therapeutic targets because of their key role in host-pathogen recognition and cell-to-cell communication. Unfortunately, the hydrophilic nature of the carbohydrate binding
BC Special Seminar: August 3, 2022
BC Special Seminar “Molecular Pharmacology for targeted cancer therapy: novel lead compounds targeting cancer cell signals” by Professor Dr. Pithi Chanvorachote Department of Pharmacology and
PGE 2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
In collaboration with Dr. Dean Thumkeo and his team, Charoensawan laboratory at Department of Biochemistry, Faculty of Science, has contributed its expertise in single-cell transcriptomic